Why Amylyx is pulling ALS drug Relyvrio from US market after study

The maker of a drug for Lou Gehrig’s disease that recently said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition. Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S.…#lougehrigs #als #fda #cambridge #massachusetts #amylyx

Source: Reuters: Health - April 4, 2024 Category: Consumer Health News Source Type: news